Amy Ly

3k citations
61 papers · 2.3k · 1 hit paper · h-index 21

Impact in

    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

Amy Ly

59 papers receiving 2.2k citations

Amy Ly's Hit Papers

Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue 2022 · 279 citations
2790+1+2Years since publication50100150200250

Peers

Amy Ly
Comparison fields: 5 of 85
  • Cancer Research 619
  • Oncology 600
  • Pulmonary and Respiratory Medicine 379
  • Pathology and Forensic Medicine 125
  • Obstetrics and Gynecology 56
Replace Luc Cabel with:
Luc Cabel France
Nike T. Beaubier United States
Sara Lock United Kingdom
Michiyo Higashi Japan
Jozef Šufliarský Slovakia
Ann E. McCullough United States
Tomoharu Sugie Japan
Alain P. Verhest Belgium
Sana Intidhar Labidi‐Galy Switzerland
Malini Harigopal United States
Amy Ly relative to Luc Cabel France Luc Cabel's profile →
Citations per field
00.5×50×116×
Luc Cabel · 1×
Citations per year

Countries citing papers authored by Amy Ly

Since Specialization
Citations

This map shows the geographic impact of Amy Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ly more than expected).

Fields of papers citing papers by Amy Ly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ly. The network helps show where Amy Ly may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Ly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Ly Line = papers co-authored together Amy Ly links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014473
2
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
Hit paper breakdown →
2022279
3 2019218
4 2015147
5 2020144
6 2020110
7 201497
8 202366
9 201358
10 202357
11 201353
12 202052
13 201741
14 201639
15 202335
16 202328
17 202427
18 201626
19 202423
20 202122

About Amy Ly

Amy Ly is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Artificial Intelligence, having authored 61 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (9 papers), AI in cancer detection (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Breast Cancer Treatment Studies (6 papers), Clinical Laboratory Practices and Quality Control (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (619 citations), Oncology (600 citations), Pulmonary and Respiratory Medicine (379 citations), Pathology and Forensic Medicine (125 citations) and Obstetrics and Gynecology (56 citations). Amy Ly has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Elena F. Brachtel, Deborah A. R. Dillon, Susan C. Lester, Bariş Boyraz, Emily Reisenbichler, Hakho Lee, Ronald Arpin, Jane E. Brock, Chang Yeol Lee and Hyunho Kim. Their work appears in journals such as The Journal of Pathology, Modern Pathology, Cancer Cytopathology, American Journal of Clinical Pathology and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact